ERN1 activation may synergistically contribute to NAFLD progression by regulating SLC11A1 expression, subsequently modulating iron metabolism and lipid deposition, indicating a potential interplay between these pathways in disease pathogenesis. The gene discussed is ERN1; the disease is metabolic dysfunction-associated steatotic liver disease.